Recombinant Human Fc-FGF21 Fusion Protein

Specification

• Cat#: THA-0349
• Product Name: Recombinant Human Fc-FGF21 Fusion Protein
• Description: Efruxifermin is an Fc-FGF21 fusion protein (human IgG1 Fc domain linked to a modified human FGF21). Efruxifermin has prolonged half-life and enhanced receptor affinity compared with native human FGF21. Efruxifermin can be used for the research of non-alcoholic steatohepatitis.
• Sequences: Human
• Molecular Weight: 91.85 kDa
• Source: HEK293
• Purity: 98.32% by SEC-HPLC
• Storage: Store at -80 centigrade for 2 years. Aliquots should be stored at the same temperature after first use to avoid multiple freeze-thaws.
• Form: Liquid
• Concentration: 4.8 mg/mL
• Endotoxin Level: < 0.094 EU/mg

Pharmaceutical Information

• Targets: FGFR; FGF21